As the FDA enforces the requirement for electronic data submission using SEND, pharmaceutical and biotech companies must adapt to this data-driven paradigm. PointCross Life Sciences emerges as a trusted partner, offering cloud-hosted or on-premises non-clinical solutions that streamline the process of becoming SEND ready. Embracing PointCross solutions empowers organizations to comply with regulatory mandates efficiently, optimize data management, and stay ahead of the curve in an increasingly data-centric industry. Contact PointCross today and embark on a seamless journey towards compliance with the FDAβs SEND mandate.
Related Posts
PHUSE US CONNECT 2024: PointCross Highlights Rapid SDTM and Compliance Dashboards
PointCross Life Sciences was thrilled by the level of interest and excitement with regards to the poster we presented... read more
Case Study: Integrated Repository of Nonclinical Studies
Integrated Repository of Nonclinical Studies: A Case Study for a Centralized, Searchable Registry of all Nonclinical Studies for Drug... read more
Interim Study Monitoring Webinar
October 19thΒ 2021 read more
PointCross Incorporates PMDA Validation Rules V4
On February 28th, 2023, PMDA released aΒ new validation rule version 4.0 for SDTMΒ (Study Data Tabulation Model) and Define.XML. A... read more